HFA Premium Access

Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living?

Event: HEART FAILURE 2016
Topic: Valvular heart disease
Session type: Satellite Symposium
Sponsored by Abbott Vascular
Date: 21 May 2016
Time: 12:45 - 13:45

Congress Session

6 presentations in this session

Introduction.

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

Why should we treat mitral regurgitation?

Speaker: Doctor M. Senni (Bergamo, IT)
Thumbnail

Functional mitral regurgitation patients: when to treat them with transcatheter mitral valve repair?

Speaker: Professor O. Alfieri (Milano, IT)
Thumbnail

More than 30000 patients treated with transcatheter mitral valve repair, can we talk about survival benefit?

Speaker: Professor R. Von Bardeleben (Mainz, DE)
Thumbnail

Functional mitral regurgitation patients: how transcatheter mitral valve repair improve their quality of life?

Speaker: Professor J. Trochu (Nantes, FR)
Thumbnail

Take home message.

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

6 speakers from this session

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
2 followers

Doctor Michele Senni

Papa Giovanni XXIII Hospital, Bergamo (Italy)
36 presentations
0 follower

Professor Ottavio Alfieri

, Milano (Italy)
4 presentations
0 follower

Professor Ralph Stephan Von Bardeleben

University Medical Center of Mainz, Mainz (Germany)
56 presentations
1 follower

Professor Jean-Noel Trochu

University Hospital of Nantes Nord Laennec, Nantes (France)
5 presentations
0 follower

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
2 followers

This platform is supported by

logo Novo Nordisk